Literature DB >> 30212804

Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey.

E Paillaud1, P Soubeyran2, P Caillet3, T Cudennec4, E Brain5, C Terret6, F Etchepare7, L Mourey8, T Aparicio9, F Pamoukdjian10, R A Audisio11, S Rostoft12, A Hurria13, C Bellera14, S Mathoulin-Pélissier14.   

Abstract

BACKGROUND: To define a core set of geriatric data to be methodically collected in clinical cancer trials of older adults, enabling comparison across trials. PATIENTS AND METHODS: Following a consensus approach, a panel of 14 geriatricians from oncology clinics identified seven domains of importance in geriatric assessment. Based on the international recommendations, geriatricians selected the mostly commonly used tools/items for geriatric assessment by domain (January-October 2015). The Geriatric Core Dataset (G-CODE) was progressively developed according to RAND appropriateness ratings and feedback during three successive Delphi rounds (July-September 2016). The face validity of the G-CODE was assessed with two large panels of health professionals (55 national and 42 international experts) involved both in clinical practice and cancer trials (March-September 2017). RESULTS AND DISCUSSION: After the last Delphi round, the tools/items proposed for the G-CODE were the following: (1) social assessment: living alone or support requested to stay at home; (2) functional autonomy: Activities of Daily Living (ADL) questionnaire and short instrumental ADL questionnaire; (3) mobility: Timed Up and Go test; (4) nutrition: weight loss during the past 6 months and body mass index; (5) cognition: Mini-Cog test; (6) mood: mini-Geriatric Depression Scale and (7) comorbidity: updated Charlson Comorbidity Index. More than 70% of national experts (42 from 20 cities) and international experts (31 from 13 countries) participated. National and international surveys showed good acceptability of the G-CODE. Specific points discussed included age-year cut-off, threshold of each tool/item and information about social support, but no additional item was proposed.
CONCLUSION: We achieved formal consensus on a set of geriatric data to be collected in cancer trials of older patients. The dissemination and prospective use of the G-CODE is needed to assess its utility.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Clinical trials; Data set; Delphi consensus; Geriatric assessment; Older patients

Mesh:

Year:  2018        PMID: 30212804     DOI: 10.1016/j.ejca.2018.07.137

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time.

Authors:  Olivia Le Saux; Claire Falandry; Hui K Gan; Benoit You; Gilles Freyer; Julien Péron
Journal:  Oncologist       Date:  2019-02-01

2.  Is the lack of evidence in older adults with cancer compromising safety?

Authors:  Darryl Outlaw; Grant R Williams
Journal:  Expert Opin Drug Saf       Date:  2020-08-05       Impact factor: 4.250

3.  Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study.

Authors:  C Baldini; E Charton; E Schultz; L Auroy; A Italiano; M Robert; E Coquan; N Isambert; P Moreau; S Le Gouill; C Le Tourneau; Z Ghrieb; J J Kiladjian; J P Delord; C Gomez Roca; N Vey; F Barlesi; T Lesimple; N Penel; J C Soria; C Massard; S Besle
Journal:  ESMO Open       Date:  2022-05-06

4.  Improving Treatment of Elderly Patients by Interprofessional Education in a Quality Network of Geriatric Medicine: Protocol for Evaluating an Educational Initiative.

Authors:  Daisy Huenefeld; Sibyll Rodde; Gertrud Bureick; Barbara Elkeles; Joachim Hasebrook
Journal:  JMIR Res Protoc       Date:  2019-05-03

5.  Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database.

Authors:  Catherine Conti; Frédéric Pamoukdjian; Thomas Aparicio; Soraya Mebarki; Johanne Poisson; Gilles Manceau; Julien Taieb; Bastien Rance; Sandrine Katsahian; Anaïs Charles-Nelson; Elena Paillaud
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

Review 6.  Irradiation of localized prostate cancer in the elderly: A systematic literature review.

Authors:  Delphine Marotte; Marie-Eve Chand-Fouche; Rabia Boulahssass; Jean-Michel Hannoun-Levi
Journal:  Clin Transl Radiat Oncol       Date:  2022-04-20

Review 7.  Understanding Treatment Tolerability in Older Adults With Cancer.

Authors:  Marie A Flannery; Eva Culakova; Beverly E Canin; Luke Peppone; Erika Ramsdale; Supriya G Mohile
Journal:  J Clin Oncol       Date:  2021-05-27       Impact factor: 44.544

8.  Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials.

Authors:  Dany Habr; Lynn McRoy; Vassiliki A Papadimitrakopoulou
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.